ORCID as entered in ROS

Select Publications
2025, Clinical relevance of zebrafish for gene variants testing. Proof-of-principle withSMN1/SMA, http://dx.doi.org/10.1101/2025.01.30.632288
,2025, Neurodevelopmental Screening in Children with Early Onset Spinal Muscular Atrophy in the Treatment Era: A Strengths-Based Cohort Study, http://dx.doi.org/10.2139/ssrn.5112747
,2024, WITHDRAWN: Eligibility for thrombolysis and outcome in pediatric acute ischemic stroke, http://dx.doi.org/10.1101/2024.07.17.24310608
,2024, Genetic newborn screening stakeholder perspectives, http://dx.doi.org/10.1101/2024.02.11.24302654
,2023, ‘The psychosocial impact of childhood dementia on children and their parents: A systematic review’, http://dx.doi.org/10.21203/rs.3.rs-2282768/v1
,“The Usual Challenges of Work are All Magnified”: Australian Paediatric Health Professionals’ Experiences During the COVID-19 Pandemic, http://dx.doi.org/10.2139/ssrn.4220687
,<i>'We Needed This'</i>: Perspectives of Parents and Healthcare Professionals Involved in a Pilot Newborn Screening Program for Spinal Muscular Atrophy, http://dx.doi.org/10.2139/ssrn.3682109
,Integrating a Pilot Newborn Screening for Spinal Muscular Atrophy Into the Australian Public Healthcare System, http://dx.doi.org/10.2139/ssrn.3814778
,